Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Semin Immunol. 2010 May 5;22(4):214–221. doi: 10.1016/j.smim.2010.04.001

γδTCR ligands and lineage commitment

Taras Kreslavsky 1, Harald von Boehmer 1
PMCID: PMC2912151  NIHMSID: NIHMS204296  PMID: 20447836

Abstract

Two major T lymphocyte lineages - αβ and γδ T cells - develop in the thymus from common precursors. Differentiation of both lineages requires signals coming from TCRs. Development of αβ T cells is driven at early stages by signaling from the pre-TCR, most likely in a ligand-independent fashion, and later – by signals delivered by αβTCRs binding to their ligands – classical or non-classical MHC molecules. γδ lineage cells likewise require TCR signaling for their differentiation. Recent work from several groups suggests that TCR signaling not only ensures the developmental progression towards αβ and γδ lineages but that signal strength instructs lineage fate: weaker TCR signal results in αβ and stronger – in γδ lineage commitment. However, as most γδTCRs remain orphan receptors, it is still debated whether strong signals from γδTCRs in development are generated in a ligand-dependent manner (as in the case of αβTCRs), ligand-independent manner (as for pre-TCR) or both. Here we summarize evidence supporting a possible role for ligands in γδ T cell lineage commitment and the generation of γδ sublineages.

Introduction

Proliferation, cell death and lineage fate decisions in multicellular organisms are guided by a limited number of molecular pathways [1]. Most of them are initiated by an interaction of a receptor – either cell surface or intracellular – with its ligand, often produced by a different cell. Presence of these two constituents – the receptor and its ligand – adds an important level of control into the system. Deregulation of this interaction can lead to malignant transformation of a cell. Indeed, most examples of ligand-independent signaling were documented in tumor cells and are the result of mutations in components of the molecular pathways that are normally triggered by a ligand – as in the case of HER2/neu [2], c-Kit [3], or Notch [4, 5].

One example of the receptors that, in collaboration with the other pathways, determine cell fate decisions in the adaptive immune system of jawed vertebrates are antigen receptors. They are distinct from most other receptor types as their diversity is generated by random recombination of gene segments. This allows for recognition of an almost infinite number of possible ligands (antigens) in the course of an immune response. Yet signals from the very same receptors control important developmental checkpoints and lineage fate decisions during early stages of immune cell differentiation.

Three types of antigen receptors exist – B cell receptors (BCRs), αβ T cell receptors (αβTCRs) and γδ T cell receptors (γδTCRs) - and each type is expressed on a corresponding lymphocyte subset and regulates its development. B cells, which differentiate in the bone marrow, separate from the other two lineages early on, whereas αβ and γδ T cells differentiate in the thymus and share a large part of their developmental programs. CD4/CD8 double negative (DN) T cell precursors in the thymus initiate rearrangement of three out of four T cell receptor (TCR) loci – Tcrb, Tcrg and Tcrd. If the Tcrb rearrangement is productive, the cell expresses the TCRβ chain in a complex with the germline encoded invariant pre-TCRα (pTα) chain. Expression of the TCRβ/pTα complex – the pre-TCR – leads to a burst of proliferation and rapid progression to the CD4/CD8 double positive (DP) stage – a hallmark of αβ lineage differentiation. The pre-TCR is a rare example of a receptor that is believed to signal in a ligand independent fashion under physiological conditions [6, 7]. Importantly, this ligand-independent signaling event is very transient as pTα expression is dampened by the time the cell progresses to the DP stage [8]. At this stage cells rearrange Tcra loci and, if the rearrangement is productive, express TCRαβ on the cell surface. Further TCR-driven fate decisions of αβ T cells in the thymus are ligand dependent (reviewed in [9]). If a cell recognizes self MHC-peptide complexes with a high affinity it is eliminated by negative selection or is diverted to a lineage with regulatory properties such as Treg. If an αβTCR fails to recognize MHC at all, the cell attempts secondary rearrangements of Tcra [10, 11] and if it still fails to generate an MHC-binding receptor the DP thymocyte deprived of TCR signal dies – so called death by neglect. Recognition of MHC-peptide complexes with moderate affinity leads to positive selection of the thymocyte and differentiation towards CD4 or CD8 sublineage – a choice also guided by TCR signal strength – with stronger (or longer) signals favoring CD4 and weaker – CD8 fate [12]. Survival of mature αβ T cells in the periphery also requires TCR ‘tickling’ by self MHC-peptide complexes [1316]. Thus most of the events in the development of αβ T cells - with the notable exception of the pre-TCR guided step– depend on triggering of their TCRs by endogenous ligands – and lack of such triggering leads to cell death.

Most cells that successfully rearrange Tcrg and Tcrd loci in a wt mouse become γδ T cells. As is the case for αβ T cells, their development requires a signal coming from TCR and in the absence of such a signal – for instance in mice deficient for the adaptor molecule LAT - developmental progression of TCRγδ expressing cells is completely blocked [17]. These cells in wt mice become functionally mature and egress to the periphery without progression through the DP stage [18]. Although the endogenous ligands for the majority of γδTCRs are unknown, it was long suspected that at least some of the γδ T cells were self-reactive [1921], because surface phenotype of many γδ T cells resembles that of antigen-stimulated αβ T cells, and they can produce cytokines shortly after stimulation or even without stimulation. The restricted TCR repertoire of peripheral γδ T cells indicated that these cells may undergo selection – possibly ligand mediated - during their development in the thymus. Recent results from several experimental systems indicate that a strong TCR signal in fact instructs commitment to the γδ lineage [2225] – and at least in one system this strong TCR signal was the result of interaction of TCR with a cognate ligand [23]. However, formal evidence for the existence of endogenous ligands is missing for most γδTCRs. Moreover, certain data suggest that at least some γδTCRs may signal in a ligand-independent fashion [26] – much like the pre-TCR [6, 7] – providing a potential alternative mechanism for the generation of the strong TCR signal. Thus, existence of endogenous γδ TCR ligands and their possible role in γδ T cell development is an area of hot debate. As another review in this issue [27] focuses on the arguments against the ‘ligand hypothesis’, we try to advocate it here. In our view neither hypothesis contradicts the bulk of the existing experimental data at the moment.

Strong TCR signals instruct commitment to the γδ lineage

αβ and γδ lineages were initially defined on the basis of TCR expression. Progression along the αβ lineage path is associated with the execution of a characteristic molecular program involving upregulation of CD4 and CD8 coreceptors, rearrangement of Tcra loci (which leads to the deletion of Tcrd encoded within Tcra) silencing of Tcrg and induction of the transcription factor Rorγt. As a common molecular program defines a lineage better than expression of a single receptor (TCR), the lineages are commonly defined on the basis of progression through the DP stage (αβ lineage) or acquisition of functionally maturity without this progression (γδ lineage).

It is important to underline a fundamental difference in currently accepted definitions of αβ and γδ lineages. The αβ lineage definition is ‘positive’ – cells that do execute the molecular program associated with progression through the DP stage. The γδ definition, on the other hand, is ‘negative’ – cells that become functionally mature and egress the thymus without progression through the DP stage. This definition is based not on a common molecular program shared by all γδ lineage cells – but rather on the lack of execution of the αβ lineage program. This leaves the possibility that γδ T cells are in fact a collection of several independent sublineages (equipollent to the αβ lineage), that do not share a common γδ lineage committed precursor (discussed in [28]). Nevertheless, as discussed below, many γδ sublineages exhibit properties indicating that they might have received strong signals from their TCRs and are suspected to have endogenous TCR ligands.

Over time it became clear that αβ and γδ molecular programs do not always correlate with the TCR type. Studies in transgenic and knock-out systems demonstrated that both αβ and γδ TCRs are compatible with both lineage fates and only the pre-TCR exclusively drives αβ lineage differentiation. Indeed, progression to DP was observed in animals that are not capable of expressing TCRs other than γδTCR such as TCRβ/ [29, 30] and pTa/TCRα/ mice [31]. On the other hand, prematurely expressed αβTCRs in TCR transgenic mice divert some cells to the γδ lineage as they became functionally mature while maintaining their endogenous Tcra loci in the germline configuration [32, 33] and not progressing through the DP stage [34]. This lack of correspondence between lineage and type of TCR seems to hold true for minor populations in wt mice [29, 35]. As the pTα can only be found in mammals, and thus the DP progression in other vertebrates has to be driven by αβ and/or γδ TCRs, these minor populations in wt mice may represent vestiges of once mainstream developmental pathways (for review see [28]).

Thus the TCR type per se does not determine the lineage fate. However, in wt mice there is a nearly perfect correlation between lineage fate and TCR. This discrepancy was resolved recently, at least in part, by studies demonstrating that TCR signal strength, rather than TCR type instructs lineage fate, with a stronger TCR signal leading to the commitment to γδ and weaker – to αβ lineage [22, 23]. These studies took advantage of the fact that both γδ and αβ lineages develop in TCRγδ transgenic mice. When TCR signal in these mice was attenuated – for instance by lck deficiency or CD3ζ hemizygosity – this led to an emergence of higher number of DP cells at the expense of γδ lineage cells [22]. On the contrary, an increase in TCR signal strength – for example on CD5−/− or CD3ζ transgenic backgrounds led to a decrease in αβ and a corresponding increase in γδ lineage cells [22].

Additional evidence for the role of TCR signal strength in αβ versus γδ lineage choice comes from a TCR transgenic system where an endogenous ligand for γδ TCR is known and so its expression can be manipulated. KN6 TCR transgenic cells recognize non-classical MHC class Ib molecules T10 and T22 [36, 37] – as do about 0.5% of total γδ T cells in spleen and thymus of a wt mouse [26]. Expression of these molecules is dependent on β2-microglubulin (β2m). In Rag deficient KN6 transgenic mice very few cells progress to DP stage and the majority stay DN, some acquiring a mature phenotype. When these mice were bred to β2m deficient background, large numbers of DP cells appeared in their thymi – at the expense of γδ T cells with a mature phenotype [23].

These results have at least two potential explanations. In the first scenario, TCR signal strength directly instructs lineage fate: a cell which receives a strong TCR signal becomes a γδ T cell, whereas a weaker signal (as in the absence of β2m) leads to adoption of αβ fate and to DP progression. In the second scenario strong TCR signal merely deletes cells, already committed to the αβ lineage, and attenuation of the signal results in the rescue of DP cells that are otherwise eliminated. The latter scenario implies that commitment occurs in a TCR independent manner. Indeed, several studies suggested that commitment to αβ and γδ lineages may occur prior to TCR expression (so-called precommitment) [38, 39]. To discriminate between these two possibilities, the lineage fate of single TCRγδ-expressing precursors in OP9-DL1 cultures (which allow for both αβ and γδ lineage differentiation [40]) was followed – as in bulk cultures and in vivo it is impossible to exclude selection. TCRγδ-positive cells from the same clones that gave rise to DP cells on OP9-DL1 monolayers were irreversibly diverted to γδ lineage when their TCRs were crosslinked with antibody [24]. Thus lineage commitment can happen after TCR expression, and TCR signal strength plays an instructive role in this process. The role of TCR signal strength in αβ versus γδ lineage choice is discussed in depth in another review in this issue [41].

As strong TCR signal is required for γδ lineage commitment, and at least in one case (KN6 TCR) generation of such strong TCR signal is a result of ligand-mediated TCR triggering, it is probable that other γδ lineage cells likewise require endogenous ligands for their differentiation.

Transcription regulators induced by strong TCR signals

Strong TCR signaling that instructs the γδ lineage fate should lead to an execution of a certain molecular program. Indeed, several transcription regulators that can be induced by strong TCR signals are expressed by γδ T cells.

It was reported that Egr family members and their target Id3 - a negative regulator of E protein function [42] - are induced by strong TCR signal in γδ lineage cells [23]. Although expression was not analyzed at the single cell level, numbers of Vγ4 cells in the spleen and Vγ5 DETCs in the skin (Vγ nomenclature after [43]) were drastically decreased in Id3 deficient animals [25] suggesting that these subsets expressed Id3, possibly in response to strong TCR signal, and their development required its expression. Moreover, KN6 transgenic cells diverted to the αβ lineage in the absence of Id3 even when the ligands were expressed, suggesting that Id3 is an important player in TCR-instructed lineage choice [25]. However, overall numbers of γδ lineage cells were increased in Id3 knockout mice – due to an increase in Vγ1Vδ6.3 cells [25, 4446]. This suggests that γδ T cells can be subdivided into Id3-dependent and independent subsets. Whether the increase in Vγ1Vδ6.3 cells in Id3−/− mice reflects a cell-intrinsic role of Id3 or is a secondary event is unclear.

Others [44, 46] and we [47] recently demonstrated that the Vγ1Vδ6.3 subset expressed the BTB-ZF family transcription factor PLZF and required its expression for proper development. PLZF had been previously reported to be expressed by invariant NKT cells [48, 49] – cells that recognize lipid antigens in context of CD1d molecules, require CD1d expression for their thymic development, and are thought to be self-reactive [50]. Thus we tested whether PLZF could be induced by a strong TCR signal. Indeed, TCR crosslinking turned on PLZF expression in polyclonal γδ thymocytes [47] suggesting that its induction in vivo likewise may be ligand dependent.

Another transcription factor of the BTB-ZF family – ThPOK - was recently demonstrated to be expressed by about half of γδ splenocytes [44]. ThPOK is crucial for CD4 αβ T cell development and is induced by relatively strong TCR signals that can be mimicked by TCR crosslinking with an antibody [51]. Interestingly, all PLZF-positive γδ T cells coexpress ThPOK [44].

The role of these transcription regulators in γδ T cell development is addressed in detail elsewhere in this issue [52]. It seems likely that - by analogy with CD4 T cells for ThPOK, KN6 transgenic cells for Id3 and cultured polyclonal γδ thymocytes for PLZF – induction of these transcription regulators in developing γδ T cells in vivo may likewise occur upon ligand mediated TCR crosslinking. Taking in account a possibility that γδ sublineages may not share a common molecular program [28], it is important to mention that both Id3-dependent and Id3-independent subsets of γδ T cells show evidence for strong TCR signaling – the former because Id3 itself is induced by a strong TCR signal, and the latter because they require TCR-inducible PLZF for functional maturation.

Restricted γδTCR repertoires may suggest ligand-mediated selection

Despite the low number of V segments, γδTCRs are potentially the most diverse antigen receptors due to their ability to utilize more than one D segment to build CDR3 loops [5355]. Yet the peripheral repertoire of γδ T cells – especially in some anatomical locations - has a strong bias towards relatively small numbers of particular γδ TCRs – often with limited junctional diversity. At a first glance this may indicate selection, possibly driven by the ligands. However, other factors can impose the limited diversity of γδ TCRs. For instance, several γδ sublineages develop during fetal/neonatal periods when terminal deoxytransferase (TdT) is not expressed and the addition of N-nucleotides is impossible. This includes Vγ5Vδ1 T cells which home to the epidermis, Vγ6Vδ1 cells found in the lungs, tongue and epithelium of the female reproductive organs and Vγ1Vδ6.3 cells found in spleen, liver and some other locations [56] – although the latter can also develop in adult thymus [47]. Another limitation of γδTCR diversity is imposed by the inability of certain TCRδ/TCRγ chain combinations to produce a functional TCR [57, 58].

Without known ligands, in most cases it is arguable whether the limited TCR diversity of γδ T cells found in certain anatomical sites is solely driven by the mechanisms described above – or whether the γδ TCR repertoire is in addition shaped by positive selection. Convincing evidence for positive selection exists for murine skin γδ T cells. This subset develops exclusively in the embryonic thymus. The cells home to the epidermis where they perform at least in part regulatory functions. Due to their characteristic morphology these cells are called dendritic epidermal T cells (DETCs). In the absence of Vγ5 or Vδ1 other γδ T cells take over the epidermal niche, adopt the characteristic morphology but exhibit different functional properties and on certain genetic backgrounds TCRδ−/− mice develop spontaneous skin inflammation that can be rescued by a transfer of fetal Vγ5+ but not Vγ5− thymocytes [59]. Moreover, in TCRδ−/− mice the niche is overtaken by αβ T cells [60]. No TCRγδ-positive cells could be detected in the skin of knock-out mice lacking several Vγ segments, including Vγ5 [61]. Expression of a Vγ4 transgene restored the DETC compartment. However, unlike Vγ5Vδ1 DETCs in wt mice, Vγ4 transgenic DETCs in these mice were highly enriched for Vδ2 positive cells – indicating a possible selection event. In the fetal thymi of these mice Vγ4Vδ4 and Vγ4Vδ5 were present, so chain pairing restrictions or preferential rearrangement of Vδ2 genes could not explain this result. Importantly, Vγ4Vδ4/Vδ5 fetal thymocytes did not acquire a mature phenotype suggesting that selection of Vγ4Vδ2 DETCs at least in part takes place in the thymus [61].

Identified or suspected endogenous γδTCR ligands: MHC and MHC-like molecules

The observation that a strong TCR signal is required for γδ lineage commitment and evidence for positive selection of some γδ T cell suggest that γδTCRs may have endogenous ligands (indirect evidence for that is summarized in Table 1). However, so far direct evidence for this is scarce (Table 2). A few MHC or MHC like molecules were suggested as possible endogenous ligands for γδ TCRs (reviewed in [55, 62]). In addition to T10/T22 discussed above, another non-classical MHC class Ib molecule – Qa-1 - was identified as a potential γδ TCR ligand [63]. This early study demonstrated that a γδ T cell hybridoma was reactive to a B-cell lymphoma cell line pulsed with poly-Glu-Tyr synthetic peptide and this reactivity could be blocked by anti Qa-1 antibodies – suggesting that this response was Qa-1 restricted [63]. However, Qa-1 is also a ligand for the CD94/NKG2C and CD94/NKG2E activating receptors [64] and thus it is possible that the γδ T cell hybridoma was activated via these receptors rather than the TCR.

Table 1.

Indirect evidence for endogenous γδTCR ligands and their possible role in γδ lineage development.

Arguments Counterarguments
Teleological:
  • Initiation of most signaling events depends on a ligand

  • Ligand-independent signaling can result in malignant transformation

  • Some signaling is believed to happen in a ligand-independent fashion (pre-TCR)

Developmental – commitment to γδ lineage:
  • Requirement for strong TCR signal to commit to γδ lineage

  • In one system strong TCR signal-instructed commitment depends on ligand

  • Not necessarily true for all γδ T cells under physiological conditions

  • Strong TCR signal could be generated without a ligand

Developmental – repertoire:
  • Although γδTCRs are potentially the most diverse antigen receptors, TCR diversity is limited – which may indicate ligand-driven selection

  • In part this is due to limited junctional diversity of fetal γδ T cells

  • Chain-pairing restrictions further limit the repertoire

  • γδ TCRs may exhibit different capabilities for ligand-independent signaling

Activated signature:
  • Many γδ T cells exhibit a surface phenotype and an ability for rapid effector responses characteristic of activated conventional αβ T cells

  • γδ T cells express transcription factors that can be induced by strong TCR signal

  • activated signature could be acquired by a different mechanism than in αβ T cells (e.g. ligand-independent TCR signaling or independently of TCR)

Spontaneous or self-induced cytokine
production:
  • some Vγ1 hybridomas produce cytokines spontaneously (autoreactivity?)

  • Vγ5Vδ1 DETC lines produce cytokines in cocultures with keratinocytes

  • Properties of primary cells are different from lines and hybridomas

  • Spontaneous production may be ligand-independent

  • keratinocytes may stimulate cells via pathways other than TCR

Physical interaction:
  • Recombinant γδTCRs can bind to surfaces of various cell lines and some primary cells

  • Formal proof of binding specificity can only be obtained when putative ligands are identified and their expression is manipulated

Table 2.

Known or suspected endogenous γδTCR ligands

Ligand Species TCR Evidence Notes Formally
proved TCR
recognition
MHC or MHC-like molecules
T10/T22 Mouse Various TCRs
with a
particular
motif in TCRδ
CDR3 loop
[94, 95]
Found as a ligand for KN6 TCR transgene [36, 37]
Was cocrystallized with TCR [94]
About 0.5% peripheral γδ T cells bind T22 tetramer [26, 95] yes
CD1c Human Vδ1 Several γδ T cell lines can be activated by CD1c-transfected cells
Reactivity can be transferred to Jurkat cells by TCR transfection [68]
Frequency of responding cells in vivo is unknown yes
MICA,
MICB
Human Vγ9Vδ1 Activate human Vδ1 T cell lines [65]
TCR transfer into a NKG2D negative cell line conferred MICA tetramer
binding [67]
Is also recognized by CD94/NKG2D receptor [66] yes
(MICA)
I-Ek Mouse Vδ4 Frequencies of Vδ4 IELs (intraepithelial lymphocytes) correlated with I-E haplotype [70] Analysis of MHC II −/− mice failed to confirm the hypothesis [71] no
Qa-1 Mouse Anti-Qa-1 antibodies block activation of a γδ hybridoma [63] No direct evidence for TCR interaction
Could act via NK cell receptors
Frequency of responding cells in vivo is unknown
no
Unrelated to MHC
Skint1 Mouse Vγ5Vδ1 Expression on thymic stroma is required for the development of Vγ5Vδ1
DETCs [76, 77]
A block observed in the absence of Skint1 can be rescued (at least on the
level of surface phenotype) by TCR crosslinking [76]
No direct evidence for TCR interaction
=> could be required for processing of the ligand or for activation
of a receptor other than TCR
no
Isopenten
yi
pyrophosp
hate
Human Vγ9Vδ2 Can stimulate Vγ9Vδ2 T cells [73] No direct evidence for TCR interaction [72]
Works at a 10 000 fold higher concentration than some microbial
phosphoantigens [72]
no
F1-ATPase Human Vγ9Vδ2 Vγ9Vδ2 cells can be activated by F1-ATPase on the surface of tumor cells
[74]
Evidence for interaction with TCR is insufficient no
insulin
B:9–23
Mouse various Hybridomas from NOD mice responded to the peptide. No requirement for
APC (single cell assays). Transfer of reactivity by TCR transfection [75].
Very high peptide concentrations (100 µg/ml) were required [75]. no
Cardiolipin Mouse Vγ1 Can enhance cytokine production by Vγ1 hybridomas [85]
Reactivity can be transferred by TCR transfection [85]
Vγ1 hybridomas produce cytokines spontaneously [19, 21]
Various treatments [19, 80, 86] including low serum culture
conditions [85] enhance cytokine production by Vγ1 hybridomas
No direct evidence for TCR interaction
no

A similar problem exists for other putative γδ TCR ligands. Human stress-induced MHC-like molecules MICA and MICB, which were shown to activate human Vδ1 T cell lines [65], are recognized by another NK cell receptor - CD94/NKG2D - which is expressed on many γδ T cells. Indeed, anti-NKG2D antibodies inhibited the responses of MICA/MICB-reactive γδ T cells [66]. However, TCR transfer from MICA-responsive but not MICA unresponsive γδ T cells into a NKG2D-negative cell line conferred MICA tetramer binding to these cells – formally demonstrating that MICA is a TCR ligand [67]. Thus MICA plays a dual role as a TCR ligand and a costimulatory molecule.

Another MHC-like molecule – CD1c – was also suggested to serve as a TCR ligand for some human γδ T cells [68]. Importantly, the authors were able to transfer the CD1c reactivity to Jurkat cells by transferring the TCR chains from responsive γδ T cell line and thus proving that TCR was specific for CD1c.

Finally, MHC class II molecules were suggested as γδ TCR ligands in mice [69, 70]. In one study the response was allogeneic [69] and thus did not represent a case of self-reactivity. In another study the frequency of Vδ4 intestinal intraepithelial γδ T cells in mice with various H-2 haplotypes was compared and it was suggested that I-Ek was involved in selection of these cells in mice [70]. However, a later report utilizing MHC class II knock-out mice failed to confirm this hypothesis [71].

Identified or suspected endogenous γδTCR ligands unrelated to MHC

Human Vγ9Vδ2 T cells can be activated by so called phosphoantigens – small phosphorylated compounds (reviewed in [72]). The most potent phosphoantigens identified so far - such as hydroxy-methyl-butyl-pyrophosphate - are bacterial metabolites. Nevertheless, isopentenyl pyrophosphate (IPP) – a compound produced by mammalian cells – can stimulate Vγ9Vδ2 T cells but at a 10 000 fold higher concentration when compared to hydroxy-methyl-butyl-pyrophosphate [73]. However, no evidence of direct binding of phosphoantigens to TCR exist so far [72]. Vγ9Vδ2 cells can be also activated by F1-ATPase that can be detected on the surface of tumor cells [74] and some data suggest that it may directly interact with the Vγ9Vδ2 TCR [74] – but the evidence for this is still incomplete.

A recent report suggests that an autologous peptide antigen may be recognized by a γδTCR [75]. In this study the authors, in an attempt to characterize insulin-responsive αβ T cells from a TCRα transgenic NOD mouse, accidentally generated a γδ hybridoma responsive to the insulin B:9–23 peptide. Although the response required very high peptide concentrations (100 µg/ml) – it was sequence-specific. The response did not require APC, as a single cell could be activated by the peptide, as judged by NFAT-LacZ reporter expression. It is unclear whether the response was dependent on MHC molecules expressed by the hybridoma. Peptide responsiveness could be transferred into a TCR-negative hybridoma by TCR transfection. Moreover, the authors were able to generate several independent B:9–23-responsive hybridomas expressing various TCRδ/TCRγ chain combinations, from NOD but not B6 mice.

Indirect, yet extremely intriguing, evidence for a γδTCR ligand exists for murine skin γδ T cells. As discussed above this population in wt mice is dominated by Vγ5Vδ1 cells. Development of the canonical Vγ5Vδ1 DETCs is blocked in one, but not the other, FvB substrain [76] – a phenotype controlled by a single gene. TCR crosslinking in culture could rescue this developmental block (as judged by a change in surface phenotype) suggesting that the phenotype might be due to a mutation in a TCR ligand. The mutation was later mapped to the novel gene Skint1 which is expressed in the thymus and skin and encodes a transmembrane protein [77] – consistent with the idea that it may be a Vγ5Vδ1 TCR ligand or a part of it. However it is possible that Skint1 performs other functions – such as costimulation or ligand processing. Physical demonstration of a Skint1-TCR interaction would be required to resolve this uncertainty. It is likewise unclear whether Skint1 is required for commitment to the γδ lineage and whether in its absence some Vγ5Vδ1 cells are diverted to the αβ lineage.

Thus, although several endogenous γδTCR ligands have been postulated, many of them were not formally proven to interact with γδTCRs, and none of the ligands or ligand candidates with the exception of T10/T22 and Skint1 were shown to play a role in γδ T cell differentiation.

Functional evidence for endogenous γδTCR ligands

In addition to the cases where molecular identities of a γδTCR ligands are known or at least suspected, in some cases functional evidence for the presence of a ligand exist - but does not point to a particular molecule.

First evidence of γδ T cell autoreactivity came from the fact that some γδ T cell hybridomas could secrete IL-2 and IL-4 without stimulation [19, 21]. The fact that the cytokine production could be blocked by anti-TCR antibodies [19, 21] and, more importantly, that the spontaneous cytokine secretion could be initiated in non-secreting TCR-negative hybridoma by transfection of TCR chains [78, 79] indicates that this property may be a result of recognition of autoantigen expressed by the hybridoma cells themselves. Interestingly, these putatively autoreactive hybridomas were Vγ1-positive and often - Vδ6-positive [8083] and were able to secrete IL-4 [21] - properties characteristic for a subset of NKT cell-like γδ T cells [84] that express the transcription factor PLZF [44, 47]. PLZF can be induced in polyclonal immature γδ thymocytes by TCR crosslinking [47] (see above). Altogether, these observations suggest that Vγ1Vδ6 TCRs may indeed recognize a self antigen. Cytokine secretion by the hybridomas was enhanced by cardiolipin (a lipid from inner mitochondrial membrane) providing one candidate antigen [85]. However, a number of other treatments, such as mycobacterial hsp60 [19, 80], synthetic peptides including poly-Glu-Tyr [86] and even culture under reduced serum concentrations [85] resulted in enhanced cytokine production. It is unclear whether some of these manipulations trigger the TCR directly, induce a ligand or activate cells in a ligand-independent way.

Similar results were obtained with primary Vγ5Vδ1 epidermal T cells and cell lines derived from them. In this case spontaneous responses were not observed - however cocultures with primary keratinocytes or keratinocyte cell lines but not fibroblasts led to the secretion of IL-2 which could be inhibited by anti-TCR antibodies [20]. Keratinocytes were irradiated, raising a possibility that a putative ligand was stress-induced. However, TCR transfer experiments were not performed, leaving a possibility that keratinocytes activate DETCs in a TCR-independent fashion. It would be interesting to see whether DETC-activating properties of keratinocytes rely on the expression of Skint1.

Recombinant γδ TCRs

A promising approach to identification of γδTCR ligands is the utilization of recombinant TCRs in combination with biochemical and/or expression cloning methods. Such tools were developed by several groups [62, 87, 88], but so far their use has been limited to cell staining. Recombinant Vγ4Vδ5 TCR specific for T10/T22 was shown to bind only to T22-expressing cells, providing some confirmation for the specificity of the approach [88]. Vγ1Vδ6.3, Vγ5Vδ1 and Vγ6Vδ1 TCR stained a variety of cell lines, including those derived from keratinocytes, fibroblasts and thymic epithelium [88]. The staining pattern for these TCR was overlapping but somewhat different, especially when Vγ1Vδ6.3 was compared to the other two TCRs, suggesting that if the binding indeed reflected the recognition of the cognate ligands, the ligands for these TCRs may be different [62, 88]. TCRs stained T and B cell-derived cell lines weakly or did not stain at all [88] but at least two of them - Vγ1Vδ6.3 and Vγ6Vδ1 - did bind to the surface of peritoneal macrophages [89]. Although several controls were made to confirm the specificity of the staining, including inhibition of the binding by pretreatment of multimerized recombinant TCRs with antibodies against variable regions of the TCR chains [62, 89], ultimate specificity tests are only possible when the actual ligands are identified. Nevertheless, it would be interesting to see what stromal and/or thymocyte populations can bind the recombinant TCRs and thus represent potential selecting cells for the developing γδ T cells.

Evidence against a role for ligands in γδ T cell lineage commitment

Although another review in this issue focuses on the arguments against the role of the ligands in γδ lineage commitment [27] we will briefly discuss some of them here.

An important observation questioning the role the ligands in γδ lineage come from the work of Jensen and colleagues [26]. They notice that unlike in the KN6 TCR transgenic system, [23] non-transgenic mice on wt or β2m deficient backgrounds have a comparable frequency of T10/T22 restricted γδ T cells. This may indicate that the cells non-transgenic mice are not diverted to the αβ lineage by an attenuation of TCR signaling. However, other explanations are possible.

β2m−/− mice lack CD8 αβ T cells – and γδ T cells are shown to compete with them for some niche [90]. Indeed, β2m−/− mice exhibited an increase in frequency of total γδ T cell [91]. Although γδ T cell subset composition was not addressed, it is possible that it would differ from that in wt mice, since different γδ T cell subsets have different abilities for homeostatic expansion upon transfer into a lymphopenic host [92].It is thus possible that similar frequencies of T10/T22 restricted cells in wt and β2m−/− mice reflect secondary accumulation of these cells in the thymi of the latter mice due to a vacant niche possibly compensating for the diversion of some cells to the αβ lineage in the absence of β2m.

Some T10/T22-restricted TCRs may also crossreact with other non β2m-dependent ligand(s). The absence of β2-microglobulin could shift the window between putative positive and negative selection in such a way that the repertoire but not the total number of T10/T22 specific cells is affected. In this regard, it is interesting that two T10/T22 specific TCRs – G8 and KN6 — have a 15-fold difference in their affinities to T22 [93] providing a sufficient range for such a shift. In such a scenario T10/T22-specific cells in β2-microglobulin −/− mice would represent at least in part a population that is deleted when β2-microglobulin is present. These putative rescued cells then may receive a sufficiently strong TCR signal to commit to the γδ lineage – either from a ligand other than T10/T22, or in a ligand independent fashion.

The authors also provide some evidence for ligand-independent γδ TCR signaling. To this end they utilize the BaF3 cell line which depends on IL-3 signaling. When these cells are transfected by chimeric molecules containing extracellular domain of protein of interest and intracellular part of human erythropoietin receptor (EPOR), which like IL-3 receptor activates the Jak-STAT pathway, only those extracellular domains that are able to aggregate can provide BaF3 survival in the absence of IL-3. Some but not all combinations of TCRγ/TCRδ chains rescued BaF3 cells cultured in the absence of IL-3. Surprisingly, however, the rescue was also observed in the case of pTα-EPOR construct – in the absence of TCRβ chain (an observation that confirms previously published results [7]). As pTα does not signal in the absence of TCRβ in vivo the rescue may be an overexpression artifact. The extent of the rescue by γδTCRs was not higher than by pTα-EPOR – so the interpretation of this result is difficult. It is also cannot be excluded that BaF3 cells themselves express γδTCR ligands.

Thus, although observations made by Jensen and colleagues provide an important piece of evidence supporting ligand-independent γδ lineage commitment, these results are still compatible with ligand-driven γδ lineage commitment.

Although selfreactivity of γδ T cells has been long suspected and recent data indicate that strong TCR signaling is required for the commitment to γδ lineage, most γδ TCRs remain orphan receptors. Without identification of their ligands or generation of compelling evidence for ligand-independent γδTCR signaling the discussion on role for ligands in γδ T cell lineage commitment remains speculative.

Acknowledgements

We thank Michael Gleimer and Diana Alvarez Arias for critical reading and helpful discussion of this review. These studies were supported by National Institutes of Health Grants R01 A145846 and R01 A151378.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Gerhart J. 1998 Warkany lecture: signaling pathways in development. Teratology. 1999;60:226–239. doi: 10.1002/(SICI)1096-9926(199910)60:4<226::AID-TERA7>3.0.CO;2-W. [DOI] [PubMed] [Google Scholar]
  • 2.Weiner DB, Liu J, Cohen JA, Williams WV, Greene MI. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature. 1989;339:230–231. doi: 10.1038/339230a0. [DOI] [PubMed] [Google Scholar]
  • 3.Duensing A, Heinrich MC, Fletcher CDM, Fletcher JA. Biology of Gastrointestinal Stromal Tumors: KIT Mutations and Beyond. Cancer Investigation. 2004;22:106–116. doi: 10.1081/cnv-120027585. [DOI] [PubMed] [Google Scholar]
  • 4.Weng AP, Ferrando AA, Lee W, Morris JPt, Silverman LB, Sanchez-Irizarry C, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306:269–271. doi: 10.1126/science.1102160. [DOI] [PubMed] [Google Scholar]
  • 5.Malecki MJ, Sanchez-Irizarry C, Mitchell JL, Histen G, Xu ML, Aster JC, et al. Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes. Mol Cell Biol. 2006;26:4642–4651. doi: 10.1128/MCB.01655-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Saint-Ruf C, Panigada M, Azogui O, Debey P, von Boehmer H, Grassi F. Different initiation of pre-TCR and gammadeltaTCR signalling. Nature. 2000;406:524–527. doi: 10.1038/35020093. [DOI] [PubMed] [Google Scholar]
  • 7.Yamasaki S, Ishikawa E, Sakuma M, Ogata K, Sakata-Sogawa K, Hiroshima M, et al. Mechanistic basis of pre-T cell receptor-mediated autonomous signaling critical for thymocyte development. Nat Immunol. 2006;7:67–75. doi: 10.1038/ni1290. [DOI] [PubMed] [Google Scholar]
  • 8.Saint-Ruf C, Ungewiss K, Groettrup M, Bruno L, Fehling HJ, von Boehmer H. Analysis and expression of a cloned pre-T cell receptor gene. Science. 1994;266:1208–1212. [PubMed] [Google Scholar]
  • 9.von Boehmer H. Selection of the T-Cell Repertoire: Receptor-Controlled Checkpoints in T-Cell Development. In: Frederick WA, editor. Advances in Immunology. Academic Press; 2004. pp. 201–238. [DOI] [PubMed] [Google Scholar]
  • 10.Buch T, Rieux-Laucat F, Forster I, Rajewsky K. Failure of HY-specific thymocytes to escape negative selection by receptor editing. Immunity. 2002;16:707–718. doi: 10.1016/s1074-7613(02)00312-6. [DOI] [PubMed] [Google Scholar]
  • 11.Borgulya P, Kishi H, Uematsu Y, von Boehmer H. Exclusion and inclusion of [alpha] and [beta] T cell receptor alleles. Cell. 1992;69:529–537. doi: 10.1016/0092-8674(92)90453-j. [DOI] [PubMed] [Google Scholar]
  • 12.Yasutomo K, Doyle C, Miele L, Fuchs C, Germain RN. The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate. Nature. 2000;404:506–510. doi: 10.1038/35006664. [DOI] [PubMed] [Google Scholar]
  • 13.Kirberg J, Berns A, von Boehmer H. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med. 1997;186:1269–1275. doi: 10.1084/jem.186.8.1269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Rooke R, Waltzinger C, Benoist C, Mathis D. Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses. Immunity. 1997;7:123–134. doi: 10.1016/s1074-7613(00)80515-4. [DOI] [PubMed] [Google Scholar]
  • 15.Takeda S, Rodewald HR, Arakawa H, Bluethmann H, Shimizu T. MHC class II molecules are not required for survival of newly generated CD4+ T cells, but affect their long-term life span. Immunity. 1996;5:217–228. doi: 10.1016/s1074-7613(00)80317-9. [DOI] [PubMed] [Google Scholar]
  • 16.Tanchot C, Lemonnier FA, Perarnau B, Freitas AA, Rocha B. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science. 1997;276:2057–2062. doi: 10.1126/science.276.5321.2057. [DOI] [PubMed] [Google Scholar]
  • 17.Prinz I, Sansoni A, Kissenpfennig A, Ardouin L, Malissen M, Malissen B. Visualization of the earliest steps of gammadelta T cell development in the adult thymus. Nat Immunol. 2006;7:995–1003. doi: 10.1038/ni1371. [DOI] [PubMed] [Google Scholar]
  • 18.Eberl G, Littman DR. Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells. Science. 2004;305:248–251. doi: 10.1126/science.1096472. [DOI] [PubMed] [Google Scholar]
  • 19.O'Brien RL, Happ MP, Dallas A, Palmer E, Kubo R, Born WK. Stimulation of a major subset of lymphocytes expressing T cell receptor gamma delta by an antigen derived from Mycobacterium tuberculosis. Cell. 1989;57:667–674. doi: 10.1016/0092-8674(89)90135-9. [DOI] [PubMed] [Google Scholar]
  • 20.Havran W, Chien Y, Allison J. Recognition of self antigens by skin-derived T cells with invariant gamma delta antigen receptors. Science. 1991;252:1430–1432. doi: 10.1126/science.1828619. [DOI] [PubMed] [Google Scholar]
  • 21.Roberts K, Yokoyama WM, Kehn PJ, Shevach EM. The vitronectin receptor serves as an accessory molecule for the activation of a subset of gamma/delta T cells. J Exp Med. 1991;173:231–240. doi: 10.1084/jem.173.1.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hayes SM, Li L, Love PE. TCR signal strength influences alphabeta/gammadelta lineage fate. Immunity. 2005;22:583–593. doi: 10.1016/j.immuni.2005.03.014. [DOI] [PubMed] [Google Scholar]
  • 23.Haks MC, Lefebvre JM, Lauritsen JPH, Carleton M, Rhodes M, Miyazaki T, et al. Attenuation of gammadeltaTCR signaling efficiently diverts thymocytes to the alphabeta lineage. Immunity. 2005;22:595–606. doi: 10.1016/j.immuni.2005.04.003. [DOI] [PubMed] [Google Scholar]
  • 24.Kreslavsky T, Garbe AI, Krueger A, von Boehmer H. T cell receptor-instructed alphabeta versus gammadelta lineage commitment revealed by single-cell analysis. J Exp Med. 2008;205:1173–1186. doi: 10.1084/jem.20072425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lauritsen JPH, Wong GW, Lee S-Y, Lefebvre JM, Ciofani M, Rhodes M, et al. Marked Induction of the Helix-Loop-Helix Protein Id3 Promotes the ir T Cell Fate and Renders Their Functional Maturation Notch Independent. Immunity. 2009;31:565–575. doi: 10.1016/j.immuni.2009.07.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Jensen KD, Su X, Shin S, Li L, Youssef S, Yamasaki S, et al. Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity. 2008;29:90–100. doi: 10.1016/j.immuni.2008.04.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Meyer C, Zeng X, Chien YH. Ligand recognition during thymic development and γδ T cell function specification. Semin Immunol. 2010 doi: 10.1016/j.smim.2010.04.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Kreslavsky T, Gleimer M, von Boehmer H. alphabeta versus gammadelta lineage choice at the first TCR-controlled checkpoint. Curr Opin Immunol. 2010 doi: 10.1016/j.coi.2009.12.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kang J, Coles M, Cado D, Raulet DH. The developmental fate of T cells is critically influenced by TCRgammadelta expression. Immunity. 1998;8:427–438. doi: 10.1016/s1074-7613(00)80548-8. [DOI] [PubMed] [Google Scholar]
  • 30.Mombaerts P, Clarke AR, Rudnicki MA, Iacomini J, Itohara S, Lafaille JJ, et al. Mutations in T-cell antigen receptor genes [alpha] and [beta] block thymocyte development at different stages. Nature. 1992;360:225–231. doi: 10.1038/360225a0. [DOI] [PubMed] [Google Scholar]
  • 31.Buer J, Aifantis I, DiSanto JP, Fehling HJ, von Boehmer H. Role of different T cell receptors in the development of pre-T cells. J Exp Med. 1997;185:1541–1547. doi: 10.1084/jem.185.9.1541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Bruno L, Fehling HJ, von Boehmer H. The alpha beta T cell receptor can replace the gamma delta receptor in the development of gamma delta lineage cells. Immunity. 1996;5:343–352. doi: 10.1016/s1074-7613(00)80260-5. [DOI] [PubMed] [Google Scholar]
  • 33.Terrence K, Pavlovich CP, Matechak EO, Fowlkes BJ. Premature expression of T cell receptor (TCR)alphabeta suppresses TCRgammadelta gene rearrangement but permits development of gammadelta lineage T cells. J Exp Med. 2000;192:537–548. doi: 10.1084/jem.192.4.537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Egawa T, Kreslavsky T, Littman DR, von Boehmer H. Lineage Diversion of T Cell Receptor Transgenic Thymocytes Revealed by Lineage Fate Mapping. PLoS ONE. 2008;3:e1512. doi: 10.1371/journal.pone.0001512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Aifantis I, Bassing CH, Garbe AI, Sawai K, Alt FW, von Boehmer H. The E delta enhancer controls the generation of CD4- CD8- alphabetaTCR-expressing T cells that can give rise to different lineages of alphabeta T cells. J Exp Med. 2006;203:1543–1550. doi: 10.1084/jem.20051711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Bonneville M, Ito K, Krecko EG, Itohara S, Kappes D, Ishida I, et al. Recognition of a self major histocompatibility complex TL region product by gamma delta T-cell receptors. Proc Natl Acad Sci U S A. 1989;86:5928–5932. doi: 10.1073/pnas.86.15.5928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ito K, Van Kaer L, Bonneville M, Hsu S, Murphy DB, Tonegawa S. Recognition of the product of a novel MHC TL region gene (27b) by a mouse [gamma][delta] T cell receptor. Cell. 1990;62:549–561. doi: 10.1016/0092-8674(90)90019-b. [DOI] [PubMed] [Google Scholar]
  • 38.Kang J, Volkmann A, Raulet DH. Evidence that gammadelta versus alphabeta T cell fate determination is initiated independently of T cell receptor signaling. J Exp Med. 2001;193:689–698. doi: 10.1084/jem.193.6.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Melichar HJ, Narayan K, Der SD, Hiraoka Y, Gardiol N, Jeannet G, et al. Regulation of gammadelta versus alphabeta T lymphocyte differentiation by the transcription factor SOX13. Science. 2007;315:230–233. doi: 10.1126/science.1135344. [DOI] [PubMed] [Google Scholar]
  • 40.Ciofani M, Knowles GC, Wiest DL, von Boehmer H, Zuniga-Pflucker JC. Stage-specific and differential notch dependency at the alphabeta and gammadelta T lineage bifurcation. Immunity. 2006;25:105–116. doi: 10.1016/j.immuni.2006.05.010. [DOI] [PubMed] [Google Scholar]
  • 41.Wiest DL. Semin Immunol. 2010 [Google Scholar]
  • 42.Murre C. Helix-loop-helix proteins and lymphocyte development. Nat Immunol. 2005;6:1079–1086. doi: 10.1038/ni1260. [DOI] [PubMed] [Google Scholar]
  • 43.Heilig JS, Tonegawa S. Diversity of murine gamma genes and expression in fetal and adult T lymphocytes. Nature. 1986;322:836–840. doi: 10.1038/322836a0. [DOI] [PubMed] [Google Scholar]
  • 44.Alonzo ES, Gottschalk RA, Das J, Egawa T, Hobbs RM, Pandolfi PP, et al. Development of Promyelocytic Zinc Finger and ThPOK-Expressing Innate {gamma}{delta} T Cells Is Controlled by Strength of TCR Signaling and Id3 3. J Immunol. 2009 doi: 10.4049/jimmunol.0903218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ueda-Hayakawa I, Mahlios J, Zhuang Y. Id3 restricts the developmental potential of gammadelta lineage during thymopoiesis. J Immunol. 2009;182:5306–5316. doi: 10.4049/jimmunol.0804249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Verykokakis M, Boos MD, Bendelac A, Adams EJ, Pereira P, Kee BL. Inhibitor of DNA Binding 3 Limits Development of Murine Slam-Associated Adaptor Protein-Dependent "Innate" gammadelta T cells. PLoS ONE. 2010;5:e9303. doi: 10.1371/journal.pone.0009303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Kreslavsky T, Savage AK, Hobbs R, Gounari F, Bronson R, Pereira P, et al. TCR-inducible PLZF transcription factor required for innate phenotype of a subset of gammadelta T cells with restricted TCR diversity. Proc Natl Acad Sci U S A. 2009;106:12453–12458. doi: 10.1073/pnas.0903895106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Kovalovsky D, Uche OU, Eladad S, Hobbs RM, Yi W, Alonzo E, et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat Immunol. 2008 doi: 10.1038/ni.1641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Savage AK, Constantinides MG, Han J, Picard D, Martin E, Li B, et al. The Transcription Factor PLZF Directs the Effector Program of the NKT Cell Lineage. Immunity. 2008 doi: 10.1016/j.immuni.2008.07.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Baldwin TA, Hogquist KA, Jameson SC. The fourth way? Harnessing aggressive tendencies in the thymus. J Immunol. 2004;173:6515–6520. doi: 10.4049/jimmunol.173.11.6515. [DOI] [PubMed] [Google Scholar]
  • 51.He X, Park K, Wang H, Zhang Y, Hua X, Li Y, et al. CD4-CD8 lineage commitment is regulated by a silencer element at the ThPOK transcription-factor locus. Immunity. 2008;28:346–358. doi: 10.1016/j.immuni.2008.02.006. [DOI] [PubMed] [Google Scholar]
  • 52.Love PE. Semin Immunol. 2010 this issue. [Google Scholar]
  • 53.Rock EP, Sibbald PR, Davis MM, Chien YH. CDR3 length in antigen-specific immune receptors. J Exp Med. 1994;179:323–328. doi: 10.1084/jem.179.1.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature. 1988;334:395–402. doi: 10.1038/334395a0. [DOI] [PubMed] [Google Scholar]
  • 55.Konigshofer Y, Chien YH. Gammadelta T cells - innate immune lymphocytes? Curr Opin Immunol. 2006;18:527–533. doi: 10.1016/j.coi.2006.07.008. [DOI] [PubMed] [Google Scholar]
  • 56.Grigoriadou K, Boucontet L, Pereira P. Most IL-4-producing gamma delta thymocytes of adult mice originate from fetal precursors. J Immunol. 2003;171:2413–2420. doi: 10.4049/jimmunol.171.5.2413. [DOI] [PubMed] [Google Scholar]
  • 57.Boucontet L, Grana M, Alzari PM, Pereira P. Mechanisms determining cell membrane expression of different gammadelta TCR chain pairings. Eur J Immunol. 2009;39:1937–1946. doi: 10.1002/eji.200939345. [DOI] [PubMed] [Google Scholar]
  • 58.Pereira P, Boucontet L. Rates of recombination and chain pair biases greatly influence the primary gammadelta TCR repertoire in the thymus of adult mice. J Immunol. 2004;173:3261–3270. doi: 10.4049/jimmunol.173.5.3261. [DOI] [PubMed] [Google Scholar]
  • 59.Girardi M, Lewis J, Glusac E, Filler RB, Geng L, Hayday AC, et al. Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation. J Exp Med. 2002;195:855–867. doi: 10.1084/jem.20012000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Jameson JM, Cauvi G, Witherden DA, Havran WL. A Keratinocyte-Responsive {gamma}{delta} TCR Is Necessary for Dendritic Epidermal T Cell Activation by Damaged Keratinocytes and Maintenance in the Epidermis. J Immunol. 2004;172:3573–3579. doi: 10.4049/jimmunol.172.6.3573. [DOI] [PubMed] [Google Scholar]
  • 61.Xiong N, Kang C, Raulet DH. Positive Selection of Dendritic Epidermal [gamma][delta] T Cell Precursors in the Fetal Thymus Determines Expression of Skin-Homing Receptors. Immunity. 2004;21:121–131. doi: 10.1016/j.immuni.2004.06.008. [DOI] [PubMed] [Google Scholar]
  • 62.O'Brien RL, Roark CL, Jin N, Aydintug MK, French JD, Chain JL, et al. gammadelta T-cell receptors: functional correlations. Immunol Rev. 2007;215:77–88. doi: 10.1111/j.1600-065X.2006.00477.x. [DOI] [PubMed] [Google Scholar]
  • 63.Vidovic D, Roglic M, McKune K, Guerder S, MacKay C, Dembic Z. Qa-1 restricted recognition of foreign antigen by a gamma delta T-cell hybridoma. Nature. 1989;340:646–650. doi: 10.1038/340646a0. [DOI] [PubMed] [Google Scholar]
  • 64.Vance RE, Jamieson AM, Raulet DH. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J Exp Med. 1999;190:1801–1812. doi: 10.1084/jem.190.12.1801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science. 1998;279:1737–1740. doi: 10.1126/science.279.5357.1737. [DOI] [PubMed] [Google Scholar]
  • 66.Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999;285:727–729. doi: 10.1126/science.285.5428.727. [DOI] [PubMed] [Google Scholar]
  • 67.Wu J, Groh V, Spies T. T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial gamma delta T cells. J Immunol. 2002;169:1236–1240. doi: 10.4049/jimmunol.169.3.1236. [DOI] [PubMed] [Google Scholar]
  • 68.Spada FM, Grant EP, Peters PJ, Sugita M, Melian A, Leslie DS, et al. Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J Exp Med. 2000;191:937–948. doi: 10.1084/jem.191.6.937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Matis LA, Fry AM, Cron RQ, Cotterman MM, Dick RF, Bluestone JA. Structure and specificity of a class II MHC alloreactive gamma delta T cell receptor heterodimer. Science. 1989;245:746–749. doi: 10.1126/science.2528206. [DOI] [PubMed] [Google Scholar]
  • 70.Lefrancois L, LeCorre R, Mayo J, Bluestone JA, Goodman T. Extrathymic selection of TCR gamma delta + T cells by class II major histocompatibility complex molecules. Cell. 1990;63:333–340. doi: 10.1016/0092-8674(90)90166-c. [DOI] [PubMed] [Google Scholar]
  • 71.Schleussner C, Ceredig R. Analysis of intraepithelial lymphocytes from major histocompatibility complex (MHC)-deficient mice: no evidence for a role of MHC class II antigens in the positive selection of V delta 4+ gamma delta T cells. Eur J Immunol. 1993;23:1615–1622. doi: 10.1002/eji.1830230733. [DOI] [PubMed] [Google Scholar]
  • 72.Bonneville M, Scotet E. Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors. Curr Opin Immunol. 2006;18:539–546. doi: 10.1016/j.coi.2006.07.002. [DOI] [PubMed] [Google Scholar]
  • 73.Tanaka Y, Morita CT, Nieves E, Brenner MB, Bloom BR. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature. 1995;375:155–158. doi: 10.1038/375155a0. [DOI] [PubMed] [Google Scholar]
  • 74.Scotet E, Martinez LO, Grant E, Barbaras R, Jenö P, Guiraud M, et al. Tumor Recognition following V[gamma]9V[delta]2 T Cell Receptor Interactions with a Surface F1-ATPase-Related Structure and Apolipoprotein A-I. Immunity. 2005;22:71–80. doi: 10.1016/j.immuni.2004.11.012. [DOI] [PubMed] [Google Scholar]
  • 75.Zhang L, Jin N, Nakayama M, O'Brien RL, Eisenbarth GS, Born WK. Gamma delta T cell receptors confer autonomous responsiveness to the insulin-peptide B:9–23. J Autoimmun. 2010 doi: 10.1016/j.jaut.2009.12.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Lewis JM, Girardi M, Roberts SJ, Barbee SD, Hayday AC, Tigelaar RE. Selection of the cutaneous intraepithelial gammadelta+ T cell repertoire by a thymic stromal determinant. Nat Immunol. 2006;7:843–850. doi: 10.1038/ni1363. [DOI] [PubMed] [Google Scholar]
  • 77.Boyden LM, Lewis JM, Barbee SD, Bas A, Girardi M, Hayday AC, et al. Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal gammadelta T cells. Nat Genet. 2008;40:656–662. doi: 10.1038/ng.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Kikuchi GE, Roberts K, Shevach EM, Coligan JE. Gene transfer demonstrates that the V gamma 1.1C gamma 4V delta 6C delta T cell receptor is essential for autoreactivity. J Immunol. 1992;148:1302–1307. [PubMed] [Google Scholar]
  • 79.Fu YX, Vollmer M, Kalataradi H, Heyborne K, Reardon C, Miles C, et al. Structural requirements for peptides that stimulate a subset of gamma delta T cells. J Immunol. 1994;152:1578–1588. [PubMed] [Google Scholar]
  • 80.Happ MP, Kubo RT, Palmer E, Born WK, O'Brien RL. Limited receptor repertoire in a mycobacteria-reactive subset of gamma delta T lymphocytes. Nature. 1989;342:696–698. doi: 10.1038/342696a0. [DOI] [PubMed] [Google Scholar]
  • 81.Ezquerra A, Wilde DB, McConnell TJ, Sturmhofel K, Valas RB, Shevach EM, et al. Mouse autoreactive gamma/delta T cells. II. Molecular characterization of the T cell receptor. Eur J Immunol. 1992;22:491–498. doi: 10.1002/eji.1830220230. [DOI] [PubMed] [Google Scholar]
  • 82.O'Brien RL, Fu YX, Cranfill R, Dallas A, Ellis C, Reardon C, et al. Heat shock protein Hsp60-reactive gamma delta cells: a large, diversified T-lymphocyte subset with highly focused specificity. Proc Natl Acad Sci U S A. 1992;89:4348–4352. doi: 10.1073/pnas.89.10.4348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Wilde DB, Roberts K, Sturmhofel K, Kikuchi G, Coligan JE, Shevach EM. Mouse autoreactive gamma/delta T cells. I. Functional properties of autoreactive T cell hybridomas. Functional properties of autoreactive T cell hybridomas. Eur J Immunol. 1992;22:483–489. doi: 10.1002/eji.1830220229. [DOI] [PubMed] [Google Scholar]
  • 84.Azuara V, Levraud JP, Lembezat MP, Pereira P. A novel subset of adult gamma delta thymocytes that secretes a distinct pattern of cytokines and expresses a very restricted T cell receptor repertoire. Eur J Immunol. 1997;27:544–553. doi: 10.1002/eji.1830270228. [DOI] [PubMed] [Google Scholar]
  • 85.Born WK, Vollmer M, Reardon C, Matsuura E, Voelker DR, Giclas PC, et al. Hybridomas expressing gammadelta T-cell receptors respond to cardiolipin and beta2-glycoprotein 1 (apolipoprotein H) Scand J Immunol. 2003;58:374–381. doi: 10.1046/j.1365-3083.2003.01315.x. [DOI] [PubMed] [Google Scholar]
  • 86.Cady CT, Lahn M, Vollmer M, Tsuji M, Seo SJ, Reardon CL, et al. Response of murine gamma delta T cells to the synthetic polypeptide poly-Glu50Tyr50. J Immunol. 2000;165:1790–1798. doi: 10.4049/jimmunol.165.4.1790. [DOI] [PubMed] [Google Scholar]
  • 87.Steele CR, Van Remoortere KC, Hayday AC. Production of a soluble gammadelta T-cell receptor to identify ligands for the murine intestinal intraepithelial gammadelta T cell population. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;786:297–304. doi: 10.1016/s1570-0232(02)00812-7. [DOI] [PubMed] [Google Scholar]
  • 88.Aydintug MK, Roark CL, Yin X, Wands JM, Born WK, O'Brien RL. Detection of cell surface ligands for the gamma delta TCR using soluble TCRs. J Immunol. 2004;172:4167–4175. doi: 10.4049/jimmunol.172.7.4167. [DOI] [PubMed] [Google Scholar]
  • 89.Aydintug MK, Roark CL, Chain JL, Born WK, O'Brien RL. Macrophages express multiple ligands for gammadelta TCRs. Mol Immunol. 2008;45:3253–3263. doi: 10.1016/j.molimm.2008.02.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.French JD, Roark CL, Born WK, O'Brien RL. {gamma}{delta} T cell homeostasis is established in competition with {alpha}{beta} T cells and NK cells. Proc Natl Acad Sci U S A. 2005;102:14741–14746. doi: 10.1073/pnas.0507520102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Correa I, Bix M, Liao NS, Zijlstra M, Jaenisch R, Raulet D. Most gamma delta T cells develop normally in beta 2-microglobulin-deficient mice. Proc Natl Acad Sci U S A. 1992;89:653–657. doi: 10.1073/pnas.89.2.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.French JD, Roark CL, Born WK, O'Brien RL. Gammadelta T lymphocyte homeostasis is negatively regulated by beta2-microglobulin. J Immunol. 2009;182:1892–1900. doi: 10.4049/jimmunol.0803165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Adams EJ, Strop P, Shin S, Chien YH, Garcia KC. An autonomous CDR3delta is sufficient for recognition of the nonclassical MHC class I molecules T10 and T22 by gammadelta T cells. Nat Immunol. 2008;9:777–784. doi: 10.1038/ni.1620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Adams EJ, Chien YH, Garcia KC. Structure of a gammadelta T cell receptor in complex with the nonclassical MHC T22. Science. 2005;308:227–231. doi: 10.1126/science.1106885. [DOI] [PubMed] [Google Scholar]
  • 95.Shin S, El-Diwany R, Schaffert S, Adams EJ, Garcia KC, Pereira P, et al. Antigen recognition determinants of gammadelta T cell receptors. Science. 2005;308:252–255. doi: 10.1126/science.1106480. [DOI] [PubMed] [Google Scholar]

RESOURCES